Pediatric Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Pediatric Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Pediatric Vaccine Trends and Forecast

The future of the global pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications. The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Pediatric Vaccine by Segment

The study includes a forecast for the global pediatric vaccine by vaccine type, technology, application, and region.

Pediatric Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent
• Multivalent

Pediatric Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Pediatric Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Infectious Disease
• Cancer
• Allergy
• Pneumococcal Disease
• Influenza
• Measles, Mumps, and Rubella (Mmr)​
• Others

Pediatric Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Pediatric Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pediatric vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pediatric vaccine companies profiled in this report include-

• Glaxosmithkline
• Merck & Co
• Sanofi
• Pfizer
• Johnson & Johnson
• Bharat Biotech International
• Serum Institute Of India

Pediatric Vaccine Market Insights

Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Features of the Global Pediatric Vaccine Market

Market Size Estimates: Pediatric vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pediatric vaccine market size by vaccine type, technology, application, and region in terms of value ($B).

Regional Analysis: Pediatric vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, applications, and regions for the pediatric vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pediatric vaccine market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the pediatric vaccine market size?

Answer: The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030.

Q.2 What is the growth forecast for pediatric vaccine market?

Answer: The global pediatric vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pediatric vaccine market?

Answer: The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

Q4. What are the major segments for pediatric vaccine market?

Answer: The future of the pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications.

Q5. Who are the key pediatric vaccine market companies?

Answer: Some of the key pediatric vaccine companies are as follows:

• Glaxosmithkline
• Merck & Co
• Sanofi
• Pfizer
• Johnson & Johnson
• Bharat Biotech International
• Serum Institute Of India

Q6. Which pediatric vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

Q7. In pediatric vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the pediatric vaccine market by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR)​, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.